The issue isn’t about getting stoned. It’s about whether the product is actually benefiting the customer who purchased it.
If we’re going to rely on science in decision-making, we should at least make certain it’s good science.
…we should be looking at modifying our historical approach to the addicted cannabis client, away from emphasis on legal consequences and mandated compliance, and towards a more patient-centered model.
Substance Use Disorders don’t appear overnight. People who develop them may use for months or years or even decades before they seek help.
…actually more of an issue now than in the 80’s, because of the presence of super-powerful opioids like fentanyl or carfentanil, and the growing risk of unintended overdose.
Producers and distributors are eager to attract the higher-end customer, mostly likely an adult daily user who needs stronger pot to manage dependence on the drug.
Although polls show Americans are broadly in favor of medical marijuana, they’re not as enthusiastic about the prospect of sharing the road with seriously stoned drivers.
An answer such as vigorous exercise or meditation or going to a meeting will never be as universally attractive to someone a few weeks sober as “well, here, why don’t you toke this?”